Schechter M, Melzer Cohen C, Zelter T, Yanuv I, et al. Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data. Diabetes Obes Metab 2023 Jun 29. doi: 10.1111/dom.15172.
PMID: 37385956